Do gene mutations impact clinical outcome in elderly acute myeloid leukemia (AML) patients?
Developing targeted therapies to combine with venetoclax in acute myeloid leukemia (AML)
Why do charities need to keep funding research into leukemia and blood cancer in general?
Re-analysis of RESONATE-2 trial of ibrutinib vs chlorambucil in CLL
The structure IC-APL and how it is helping APL patients in developing countries